$CBIS Up to date company activities and other important

New Post Public Reply Private Reply Replies (0) Message Board
Emylers
$CBIS Up to date company activities and other important information about $CBIS

$CBIS

DD Notes ~ http://www.ddnotesmaker.com/CBIS

##### recent news/filings ~ source: finance.yahoo.com

Fri, 10 Jan 2014 13:04:28 GMT ~ A Smokey Bubble On The Horizon
- (Editors' Note: This article covers micro-cap stocks. Please be aware of the risks associated with these stocks.) I was thinking of starting this article out by quoting Jimi Hendrix "Purple Haze", ...
read full: http://seekingalpha.com/article/1938411-a-smo...urce=yahoo
*********************************************************

Thu, 02 Jan 2014 18:15:46 GMT ~ Up in Smoke: Marijuana Stocks Fly High as Colorado Law Takes Effect
- Shares of volatile marijuana stocks like Medbox soared following the launch of legalized recreational pot use in Colorado.
read full: http://www.foxbusiness.com/investing/2014/01/...es-effect/
*********************************************************

Mon, 02 Dec 2013 18:56:00 GMT ~ Cannabis Science (CBIS) Moves Forward with Critical Support of Landmark Federal Cannabis Legislative Initiative
- COLORADO SPRINGS, Colo., Dec. 2, 2013 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is a key leader in the private sector challenge to end the restrictions on cannabis drug development and research in the U.S. "The Cannabinoid Scientific Research and Development Act," which will be submitted for congressional review in the U.S. Senate and House of Representatives by the end of January 2014, is landmark legislation seeking equal treatment for cannabinoid scientific research. In addition, the legislation aims to provide the framework for the clinical investigation of the hundreds of strains of cannabis and their constituent cannabinoids regarding their medical efficacy on a wide range of life-threatening, chronic, and infectious diseases. The legislation also seeks to provide "an informed clinical environment for physicians, researchers and consumers to make effective clinical choices regarding their therapeutic treatments for a variety of diseases," said Dr. Robert Melamede, President, Cannabis Science. "We need rational federal standards based upon science to replace inadequate public policies rooted in the misperceptions of the past," Dr. Melamede added.
read full: http://finance.yahoo.com/news/cannabis-scienc...00113.html
*********************************************************

Wed, 27 Nov 2013 18:04:11 GMT ~ CANNABIS SCIENCE, INC. Financials
read full: http://finance.yahoo.com/q/is?s=cbis
*********************************************************

Mon, 25 Nov 2013 19:29:00 GMT ~ Cannabis Science Working With cannabis caucus in the U.S. House of Representatives in the Fight to Level the Playing Field for Cannabis Drug Research and Development
- COLORADO SPRINGS, Colo., Nov. 25, 2013 /PRNewswire/ -- (NASDAQ OTC: CBIS) Cannabis Science, Inc., a U.S. Company specializing in cannabis formulation-based drug development, is working with the the cannabis caucus in the U.S. House of Representatives to initiate substantial changes in 2014 in the way cannabis research and drug development can be done in this country. Working with leading exponents of cannabis drug research and development and a bi-partisan coalition in Congress, CBIS has drafted legislation as the template for these ground-breaking changes and is working with other interested parties for its passage early next year. "We expect ground breaking changes in 2014 in our ability to conduct clinically-related drug research with cannabinoids," said Dr. Robert Melamede, president, Cannabis Science. "We will have a definitively clearer pathway for much needed clinical research on cannabinoids next year that will allow us to determine the clinical affect of dozens of different strains of cannabis for chronic and infectious disease," Dr. Melamede said.
read full: http://finance.yahoo.com/news/cannabis-scienc...00363.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=CBIS&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=CBIS&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/CBIS/company-info
Ticker: $CBIS
OTC Market Place: OTCQB
CIK code: 0001024626
Company name: Cannabis Science, Inc.
Company website: http://www.cannabisscience.com
Incorporated In: NV, USA

##### extra dd links

Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/CBIS/filings
Latest financials: http://www.otcmarkets.com/stock/CBIS/financials
Latest news: http://www.otcmarkets.com/stock/CBIS/news - http://finance.yahoo.com/q/h?s=CBIS+Headlines

Major holdings: http://data.cnbc.com/quotes/CBIS/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=CBIS+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/CBIS.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=CBIS

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Cannabis+Science%2...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...nce%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.cannabisscience.com
Alexa: http://www.alexa.com/siteinfo/http://www.cann...ience.com#
Corporate website internet archive: http://web.archive.org/web/*/http://www.cannabisscience.com

http://www.pennystocktweets.com/stocks/profile/CBIS

##### last known share structure ~ source: otcmarkets.com

Market Value: $111,914,614 a/o Jan 09, 2014
Shares Outstanding: 761,323,906 a/o Nov 18, 2013
Float: 24,000,000 a/o Jun 17, 2010
Authorized Shares: 250,000,000 a/o Jun 17, 2010
Par Value: 0.001

##### business description ~ source: otcmarkets.com

Research & Development of medical cannabis compounds

DD Notes ~ http://www.ddnotesmaker.com/CBIS

Scroll down for more posts ▼

Top 10 Most Recent News Articles

VeriSilicon's GLTiny: Game-Changer for Wearable Tech

Updated Category News Views 58

Revolutionizing Wearable Graphics with GLTiny There's a fresh breeze blowing through the world of wearable tech, and VeriSilicon's GLTiny seems to be at the heart of it. When the silicon giant out of Shanghai tossed GLTiny into the mix, it wasn't just throwing another chip on the barbie. Oh no, this is a real pivot towards juicing up those smart gadgets strapped to your...

Continue Reading
Factory-Built Homes Take Center Stage in New Doc Short

Updated Category News Views 109

Housing is one of those things we all think we understand until we start peeling back the layers of its history, especially when factory-built homes are involved. Here's a new angle: Clayton has just released the teaser for their documentary short, "Built: A Story of Factory-Built Housing in America," and it's turning the lights on a sector that's often left in the...

Continue Reading
Guidewire's 2026 Awards Highlight AI in Insurance Shift

Updated Category News Views 44

AI Takes Center Stage at Guidewire's Annual Gala Change is constant, but when it comes with a potent mix of AI and insurance, you know things are about to get interesting. Guidewire Software (NYSE: GWRE) is tipping its hat to Beazley, Definity, and RCIS, the standouts at its annual Innovation Awards. Held during their CONNECTIONS Conference in Las Vegas, this year's...

Continue Reading
UPM's WISA Group Demerger: A Strategic Shift

Updated Category News Views 136

UPM's Bold Move on the Chessboard In a market that's no stranger to seismic tremors, UPM's decision to move forward with the partial demerger of its Kymmene Corporation is something that raises a few eyebrows. But hey, isn't shaking things up half the fun in this business? The Finnish Financial Supervisory Authority giving a thumbs-up to the supplement listing for WISA...

Continue Reading
Markel Stays the Course: Solid Q3 Results in 2026

Updated Category News Views 152

Markel Group's Steady Climb Doesn't Falter Diving right into it, Markel Group's latest figures prove they're not just treading water. The insurance giant, trading under NYSE:MKL, reported solid third quarter results for 2026. And while some numbers might not be breaking records, they sure paint a picture of a company that's weathering the market with some grit. The...

Continue Reading
United Imaging Surges with 19.43% Revenue Growth in 2026

Updated Category News Views 0

United Imaging's Remarkable Revenue Surge Coming out of Shanghai, we've got some major numbers to chew on. United Imaging Healthcare (688271.SH)—this isn't your run-of-the-mill medical tech firm—is bringing some serious heat to the market with a 19.43% bump in revenue. We're talking RMB 10.58 billion raked in over just the first nine months of 2026. Those are hefty...

Continue Reading
Beta Bionics: Investors on Edge, Legal Moves Underway

Updated Category News Views 73

A Tumultuous Time for Beta Bionics Investors Trouble's brewing for those holding Beta Bionics, Inc. (NASDAQ: BBNX) shares. This isn't just market jitters—it's a full-blown legal tussle. The shareholder-rights law honchos at Johnson Fistel are sounding the alarms, and investors better heed their call before the clock strikes November 3, 2026. There's a class action...

Continue Reading
2026 Data Integration Stars: User Sentiments Revealed

Updated Category News Views 65

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Continue Reading
MGM China Hits Record Highs Amid Market Challenges

Updated Category News Views 59

Highs Amid Headwinds: MGM China's Standout Quarter Rolling into one's portfolio, MGM China isn't just coasting along—it's smashing some records, despite fierce headwinds. It's not all smooth sailing in Macau's gaming scene, but MGM China has hammered out its third-quarter results with gusto, setting new records for revenue and adjusted EBITDA. These folks aren't just...

Continue Reading
Data Breach at Lumara Bio: Privacy Lawsuits Loom

Updated Category News Views 206

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Continue Reading
=2">More News Articles